Author:
Kimura Morihiko, ,Tominaga Takeshi,Takatsuka Yuichi,Toi Masakazu,Abe Rikiya,Koyama Hiroki,Takashima Shigemitsu,Nomura Yasuo,Miura Shigeto,Kimijima Izo,Tashiro Hideya,Ohashi Yasuo
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference21 articles.
1. Bonadonna G, Brusamolino E, Valagusa P. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med. 1976;294:405–10.
2. Early Breast Cancer Trialists’ Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. 133 randomized trials involving 31,000 recurrences and 24,000 death among 75,000 women. Lancet. 1992;339:1–15.
3. Nomura Y, Tominaga T, Adachi I, Koyama H, Fukami A. Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan. Gan To Kagaku Ryoho. 1994;21(12):1949–56.
4. Early Breast Cancer Trialists’ Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet. 1998;351(9114):1451–67.
5. Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deshler A, et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst. 2001;93(13):979–89.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献